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ABSTRACT
Introduction: Gastroesophageal reflux disease (GERD) is a highly prevalent condition 
in the Western world. It is a frequent cause of medical appointments and has a high 
impact on quality of life (QOL). This study aimed to assess health-related quality of life 
(HQ-QOL) of patients with non-erosive gastroesophageal disease (NERD) and compare 
their scores with the scores of patients with GERD symptoms and non-pathological 
acid reflux (non-NERD). 
Methods: We studied 42 patients with GERD symptoms—21 with positive pHmetry 
for acid reflux (NERD group) and 21 with negative pHmetry for acid reflux (non-NERD 
group). We enrolled patients matched by age and gender. Patient inclusion criteria 
were based on clinical and endoscopic findings and pHmetry. All other major diseases 
having an impact on QOL were excluded as well as patients in regular use of proton 
pump inhibitors, prokinetics, histamine-2 receptor antagonists and anti-depressants. 
All subjects were asked to fill in a validated translation of the SF-36 questionnaire. 
We described scores trough median and interquartile range (IQR) and assessed the 
significance of the comparisons through Mann-Whitney test and chi-square test or 
Student’s t-test when appropriate. 
Results: We found no significant differences in the eight domains of SF-36 between 
the two groups. 
Conclusion: QOL of patients with GERD symptoms was equivalent, regardless of 
acid reflux at pHmetry.
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Gastroesophageal reflux disease (GERD) is a complex, chronic, and relapsing 
condition with morbidity and potential for complications. Montreal consensus 
defines GERD as “[...] a condition which develops when the reflux of stomach 
contents causes troublesome symptoms and/or complications”1:5. GERD can 
be classified as erosive esophagitis (EE) or non-erosive reflux disease (NERD). 
EE is defined as esophageal mucosal lesions at upper gastrointestinal (GI) 
endoscopy, while NERD is characterized by typical symptoms (heartburn 
plus acid regurgitation) and no changes at endoscopy2. Patients with frequent 
heartburn have a negative impact on their quality of life (QOL)3.
The traditional way of assessing health changes in patients is very often 
focused on objective clinical or biological tests. Whereas these tests offer 
information about pathological processes, it is impossible to separate the 
disease itself from the individual’s personal point of view regarding their well-
being and social perspective. One way to assess this aspect is to measure 
their QOL4.
Our aim was to compare health-related quality of life (HR-QOL) of patients 
with GERD symptoms and non-erosive gastroesophageal disease (NERD) 
with patients with non-pathological reflux at pH esophageal monitoring.
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METHODS
We recruited 57 adult patients (over 18 years 
old) with GERD symptoms and normal esophageal 
mucosa at upper GI endoscopy. Of those, we 
included in this study 42 adult patients with GERD 
symptoms and normal esophageal mucosa at upper 
GI endoscopy, from November of 2004 to August 
of 2005. Patients were divided into two groups 
according to pHmetry results: NERD and non-NERD. 
NERD group included patients with abnormal acid 
reflux at pHmetry. non-NERD group encompassed 
patients with normal pHmetry. We excluded illiterate 
patients as well as patients in regular use of pump 
proton inhibitors, prokinetics, histamine-2 receptor 
antagonists, and anti-depressants. All patients showed 
typical symptoms of GERD, such as heartburn and 
acid regurgitation, and some atypical symptoms, 
such as chest pain, swallowing difficulties, and 
pharyngeal globus. They did not show symptoms 
of dyspepsia syndrome. We did not include patients 
with chronic disease that could affect QOL adversely, 
such as cardiovascular disease, chronic kidney 
disease, obstructive pulmonary disease, cirrhosis, 
rheumatologic diseases, and any history of cancer.
We asked the patients to fill in a SF-36 questionnaire 
validated for Portuguese5. The SF-36 questionnaire 
measures generic QOL as well as health status in eight 
domains: vitality, physical functioning, bodily pain, 
general health perceptions, physical role functioning, 
emotional role functioning, mental health, and social 
functioning. Two summary scores were calculated 
based on subjects’ responses: physical health (PH) 
score and mental health (MH) score. SF-36 scores 
range from 0 to 100 in each dimension and in summary 
scales, with higher scores indicating better QOL6.
Data were tabulated in Microsoft Excel and then 
analyzed using SPSS version 18. We described 
categorical variables (gender and symptoms) through 
absolute and relative frequencies. Age was described 
through mean and standard deviation. SF-36 domain 
scores were described through median and interquartile 
range (IQR). Significance was assessed through 
Student’s t-test, qui-square test, and Mann-Whitney 
test when appropriate. We considered p-values less 
than 0.05 as significant.
The present study complied with the standards of 
Helsinki Declaration. The Institutional Review Board 
of our institution reviewed and approved our protocol. 
All patients signed an informed consent form before 
enrollment in the study.
RESULTS
We excluded 15 patients from the study—five 
patients did not accomplish esophageal pH monitoring 
and 10 did not return the questionnaire. Therefore, 
we analyzed data from 42 patients. Each group 
included 15 women and six men. Mean age was 
47.5 (±11.9) in the NERD group and 43.9 (±13.3) in 
the non-NERD group, with no significant difference 
(p = 0.366).
Twenty-one (50%) patients had NERD. There were 
no statistically significant differences in the standardized 
scores of SF-36 domains between NERD and 
non-NERD patients. Table 1 shows data comparing 
the scores of SF-36 domains between NERD and 
non-NERD patients.
DISCUSSION
With the aim of studying QOL in patients with GERD 
symptoms, mainly heartburn and acid regurgitation, we 
found no significant differences in any domain of the 
SF-36 questionnaire among patients who presented 
positive or negative pHmetry for acid reflux.
GERD is a common disease with lasting symptoms 
leading to a chronic condition with impact on QOL. 
Even though heartburn is the most common symptom, 
there is no evidence whether its severity correlated 
with the degree of injury in esophageal mucosa7. 
Similarly, we did not find a significant association 
between discomfort perception and presence or 
absence of pathological acid reflux detected by 
pHmetry in our patients. In the present study, we 
evaluated patients who had typical and atypical 
symptoms, but their main complaint was heartburn, 
which was equally distributed among those with and 
without pathological acid reflux.
Esophageal mucosa damage and clinical 
symptoms have a complex pathogenesis, and patient 
perception is a subjective issue linked to the complex 
phenomenon of visceral sensations. Patients with no 
relationship between symptoms and acid reflux at 
pHmetry presented a high level of anxiety8.
NERD patients represent up to 60% of all 
patients with reflux symptoms, but the mechanisms 
involved in the pathogenesis of NERD are complex 
and multifactorial9. The non-NERD patients in our 
sample could be included in the following categories: 
sensitive esophagus (to acid and non-acid reflux) or 
functional heartburn. Presentation of esophageal 
hypersensitivity and GERD may be the same, and 
pHmetry may show reflux symptoms related to normal 
acid exposure9. Since our non-NERD patients did 
not present symptoms related to the events of acid 
reflux, we can rule out acid hypersensitivity in those 
patients. pH-impedance monitoring is able to detect 
non-acid reflux, but since we did not perform it, we 
could not identify those patients in our sample.
When comparing SF-36 domain scores in our 
patients with NERD and non-NERD, we observed no 
difference in any item. This supports the hypothesis 
http://seer.ufrgs.br/hcpa Clin Biomed Res 2017;37(2) 61
Quality of life in non-erosive gastroesophageal reflux disease
that other variables, such as functional disorders 
(visceral hyperalgesia and allodynia), can also be 
found in these patients. Our results agree with those 
from a study that demonstrated that reflux symptom 
severity and general QOL scores of erosive esophagitis 
in NERD patients were similar10.
The definition of functional heartburn criteria has 
evolved over the years. Rome II criteria included 
acid sensitive esophagus in the functional heartburn 
group. This conception was revised by ROME III and 
classified as part of the NERD group11. Rome IV defined 
functional heartburn as heartburn with no evidence for 
GERD, no correlation with reflux symptom, and with 
a negative response to acid-suppressive therapy12.
Little is known about the pathogenesis of functional 
heartburn. Zerbib et al.13 showed no significant 
difference between functional heartburn patients and 
controls regarding intercellular esophageal distance. 
The authors also demonstrated that heartburn might 
be perceived despite the maintenance of mucosa 
integrity. Farre et al. also showed that the presence of 
intercellular esophageal distance alone is not sufficient 
to generate symptoms, at least in healthy subjects in 
whom esophageal perfusions of acid and bile were 
performed14. Moreover, we recently showed that the 
number of total acid and weakly acid refluxes does 
not differ between functional heartburn and control 
subjects and is significantly lower than in the two 
subsets of NERD (pH-positive and HE). Patients with 
functional heartburn who report heartburn without any 
correlation with gastroesophageal reflux events seem 
to be more sensitive to mechanical and chemical 
stimuli than NERD patients13. Further studies are 
needed to better clarify the mechanisms of symptom 
generation in patients with gastroesophageal reflux 
and functional heartburn15.
Our study has some limitations. One of them is 
the small sample, but the equal number and similarity 
of patients in both groups might provide internal 
validity to the study, but prevent inferences about 
the general population. Another possible bias is 
that the main psychiatric diseases that could affect 
HR-QOL were not assessed. Therefore, we cannot 
tell what specific influence psychological variables 
could have on our results. We believe that the equal 
number of patients in both groups and their similarity 
in terms of mental and emotional domains lessened 
this limitation. We need to replicate this study with a 
broader sample, controlling for psychological variables 
and their influence on symptoms to make inferences 
about the general population.
In conclusion, our study showed impairment of 
QOL in patients with reflux symptoms regardless of 
their pHmetry results. Symptom perception is more 
relevant to patients than the results of diagnostic tests.
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Table 1: SF-36 domain scores for both groups.
Domains NERD n = 21 non-NERD n = 21 p*Median (P25-P75) Median (P25-P75)
Functional capacity 52.9 (49.9-55.0) 50.9 (39.4-57.1) 0.493
Physical aspects 56.2 (38.6-56.2) 42.1 (35.0-56.2) 0.123
Pain 51.6 (37.3-62.7) 41.8 (37.5-54.2) 0.196
Overal health status 55.6 (46.2-57.9) 53.2 (43.9-57.9) 0.577
Vitality 51.4 (45.5-62.1) 46.7 (39.6-55.0) 0.240
Social aspects 46.3 (29.9-57.1) 40.9 (32.7-54.4) 1.000
Emotional aspects 34.2 (29.0-55.3) 44.6 (34.3-55.3) 0.290
Mental health 48.2 (39.1-56.2) 45.9 (34.5-55.0) 0.504
Physical health 55.8 (44.1-58.5) 47.8 (37.7-57.1) 0.090
Mental health 41.6 (34.1-54.9) 44.3 (34.6-55.1) 0.850
*Mann-Whitney test.
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